ResMed Inc. (RMD)

Healthcare · Medical Instruments Supplies · NYSE

S&P 500

ResMed Inc. (RMD) is a Healthcare company in the Medical Instruments Supplies industry. It has a market capitalization of $32.02B, a trailing price-to-earnings ratio of 19.9 and a free-cash-flow yield of 3.9%. Over the most recent reported fiscal year, revenue grew 10.9% and free cash flow per share grew 129.8%.

Market cap	$32.02B
Trailing P/E	19.9
FCF yield	3.9%
Revenue growth (YoY)	+10.9%
EPS growth (YoY)	+19.8%
FCF/share growth (YoY)	+129.8%
Exchange	NYSE
Sector	Healthcare
Industry	Medical Instruments Supplies

Explore live RMD data on Nama Insights →

Recent Congressional trades

ResMed Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Thomas H Tuberville	Senate	Sell	$1,001 - $15,000	Aug 5, 2026
Thomas H Tuberville	Senate	Sell	$1,001 - $15,000	Aug 5, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Kelly Louise Morrison	House	Sell	$1,001 - $15,000	Jun 18, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	Feb 13, 2025
Thomas R Carper	Senate	Sell	$1,001 - $15,000	—
Thomas R Carper	Senate	Sell	$1,001 - $15,000	—
Thomas R Carper	Senate	Buy	$1,001 - $15,000	—